Literature DB >> 3502102

Retroviral mediated transfer and expression of human alpha 1-antitrypsin in cultured cells.

F D Ledley1, H E Grenett, D P Bartos, S L Woo.   

Abstract

Genetic deficiency of alpha 1-antitrypsin in man is a predisposing factor to emphysema and a disorder potentially correctable by somatic gene therapy. A full-length human alpha 1-antitrypsin cDNA was cloned into a retroviral vector and introduced into cells which package the recombinant gene in a retroviral capsule. Cells infected with the recombinant retrovirus express human alpha 1-antitrypsin mRNA and protein. The recombinant protein is glycosylated, secreted and exhibits anti-protease activity against human neutrophil elastase.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3502102     DOI: 10.1016/0378-1119(87)90370-2

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  3 in total

Review 1.  Recent advances in somatic gene therapy for hereditary respiratory diseases.

Authors:  C A Owen
Journal:  Thorax       Date:  1992-04       Impact factor: 9.139

Review 2.  Human gene therapy: present and future.

Authors:  M A Kay; K P Ponder; S L Woo
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

3.  Approaches to maximizing stable expression of alpha 1-antitrypsin in transformed CHO cells.

Authors:  T Paterson; J Innes; S Moore
Journal:  Appl Microbiol Biotechnol       Date:  1994-01       Impact factor: 4.813

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.